News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements
Optimi Health
Core One Labs’ Files Milestone Patent for Protection of its Recombinant Production System for Optimized Biosynthetic N-methyltryptamine (NMT)
Core One Labs Inc.
Tryp Therapeutics Inc. Announces Upsizing Of Previously Announced Private Placement
Tryp Therapeutics
Blackhawk Subsidiary Digital Mind Technology Starts Phase 1 Development of Digital Therapeutic Platform and is on Track for Completion in Q2, 2022
MindBio Therapeutics
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules
Awakn Life Sciences
NeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, Ontario
NeonMind Biosciences Inc.
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine
ATAI Life Sciences
Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules
Mydecine Innovations Group
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
Optimi Health
Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism
Nova Mentis Life Science
Novamind Advances Clinical Pilot for Frontline KAP
Novamind Inc.
Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update
Field Trip Health
Enveric Biosciences Announces Closing of $10 Million Public Offering
Enveric Biosciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.